Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ana Huerta

Showing results (51-60 of 60) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 60 results.
Kidney International|August 18, 2019
Severe and malignant hypertension are common in primary atypical hemolytic uremic syndromeTeresa Cavero, Emilia Arjona, Karina Soto, et al.
Clinical Journal of the American Society of Nephrology : CJASN|November 8, 2019
Complement Activation and Thrombotic MicroangiopathiesMarta Palomo, Miquel Blasco, Patricia Molina, et al.
ESC Heart Failure|February 28, 2025
Clinical utility and safety of finerenone in patients with heart failure: Rationale and design of FINE registryGonzalo Luis Alonso Salinas, Amaia Martínez León, Diego Aguiar Cano, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 28, 2020
Validation of a Histologic Scoring Index for C3 GlomerulopathyFernando Caravaca-Fontán, Hernando Trujillo, Marina Alonso, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 29, 2021
Longitudinal change in proteinuria and kidney outcomes in C3 glomerulopathyFernando Caravaca-Fontán, Montserrat Díaz-Encarnación, Virginia Cabello, et al.
Clinical Kidney Journal|August 25, 2022
Development and validation of a nomogram to predict kidney survival at baseline in patients with C3 glomerulopathyFernando Caravaca-Fontán, Marta Rivero, Teresa Cavero, et al.
Kidney360|March 30, 2023
Clinical Profiles and Patterns of Kidney Disease Progression in C3 GlomerulopathyFernando Caravaca-Fontán, Teresa Cavero, Montserrat Díaz-Encarnación, et al.
Clinical Journal of the American Society of Nephrology : CJASN|August 21, 2020
Mycophenolate Mofetil in C3 Glomerulopathy and Pathogenic Drivers of the DiseaseFernando Caravaca-Fontán, Montserrat M Díaz-Encarnación, Laura Lucientes, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 7, 2023
Sodium-glucose cotransporter 2 inhibition in primary and secondary glomerulonephritisFernando Caravaca-Fontán, Kate Stevens, Maite Padrón, et al.
Nature Genetics|June 19, 2023
Genome-wide association analyses define pathogenic signaling pathways and prioritize drug targets for IgA nephropathyKrzysztof Kiryluk, Elena Sanchez-Rodriguez, Xu-Jie Zhou, et al.
Pageof 6

Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
Kidney International|August 18, 2019
Severe and malignant hypertension are common in primary atypical hemolytic uremic syndromeTeresa Cavero, Emilia Arjona, Karina Soto, et al.
Clinical Journal of the American Society of Nephrology : CJASN|November 8, 2019
Complement Activation and Thrombotic MicroangiopathiesMarta Palomo, Miquel Blasco, Patricia Molina, et al.
ESC Heart Failure|February 28, 2025
Clinical utility and safety of finerenone in patients with heart failure: Rationale and design of FINE registryGonzalo Luis Alonso Salinas, Amaia Martínez León, Diego Aguiar Cano, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 28, 2020
Validation of a Histologic Scoring Index for C3 GlomerulopathyFernando Caravaca-Fontán, Hernando Trujillo, Marina Alonso, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 29, 2021
Longitudinal change in proteinuria and kidney outcomes in C3 glomerulopathyFernando Caravaca-Fontán, Montserrat Díaz-Encarnación, Virginia Cabello, et al.
Clinical Kidney Journal|August 25, 2022
Development and validation of a nomogram to predict kidney survival at baseline in patients with C3 glomerulopathyFernando Caravaca-Fontán, Marta Rivero, Teresa Cavero, et al.
Kidney360|March 30, 2023
Clinical Profiles and Patterns of Kidney Disease Progression in C3 GlomerulopathyFernando Caravaca-Fontán, Teresa Cavero, Montserrat Díaz-Encarnación, et al.
Clinical Journal of the American Society of Nephrology : CJASN|August 21, 2020
Mycophenolate Mofetil in C3 Glomerulopathy and Pathogenic Drivers of the DiseaseFernando Caravaca-Fontán, Montserrat M Díaz-Encarnación, Laura Lucientes, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 7, 2023
Sodium-glucose cotransporter 2 inhibition in primary and secondary glomerulonephritisFernando Caravaca-Fontán, Kate Stevens, Maite Padrón, et al.
Nature Genetics|June 19, 2023
Genome-wide association analyses define pathogenic signaling pathways and prioritize drug targets for IgA nephropathyKrzysztof Kiryluk, Elena Sanchez-Rodriguez, Xu-Jie Zhou, et al.
Pageof 6